The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Smith David Ross since year 2005.
The trader's CIK number is 1650274.
At the time of the last reporting, Smith David Ross was the Corporate Executive VP & CFO of Charles River Laboratories International, Inc. .
(stock ticker symbol CRL).
See this page for all insider trading activities at Charles River Laboratories International, Inc. .
Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|---|
2019-08-12 | CRL | Charles River Laboratories International, Inc. | Option Ex | 1,249 | 76.12 | 95,073 |
2019-08-12 | CRL | Charles River Laboratories International, Inc. | Sale | 1,249 | 130.64 | 163,166 |
2019-02-27 | CRL | Charles River Laboratories International, Inc. | Sale | 2,158 | 141.05 | 304,377 |
2019-02-27 | CRL | Charles River Laboratories International, Inc. | Option Ex | 2,158 | 76.67 | 165,453 |
2019-02-26 | CRL | Charles River Laboratories International, Inc. | Sale | 1,587 | 141.57 | 224,668 |
2019-02-26 | CRL | Charles River Laboratories International, Inc. | Option Ex | 4,187 | 73.70 | 308,581 |
2019-02-26 | CRL | Charles River Laboratories International, Inc. | Sale | 4,050 | 139.80 | 566,181 |
2018-11-12 | CRL | Charles River Laboratories International, Inc. | Sale | 1,866 | 134.46 | 250,904 |
2018-08-13 | CRL | Charles River Laboratories International, Inc. | Sale | 1,249 | 120.17 | 150,092 |
2018-08-13 | CRL | Charles River Laboratories International, Inc. | Option Ex | 1,249 | 76.12 | 95,073 |
2018-05-01 | CRL | Charles River Laboratories International, Inc. | Option Ex | 945 | 51.45 | 48,620 |
2018-05-01 | CRL | Charles River Laboratories International, Inc. | Sale | 945 | 104.23 | 98,502 |
2018-02-28 | CRL | Charles River Laboratories International, Inc. | Option Ex | 4,365 | 88.05 | 384,338 |
2018-02-28 | CRL | Charles River Laboratories International, Inc. | Sale | 5,240 | 107.90 | 565,385 |
2018-02-28 | CRL | Charles River Laboratories International, Inc. | Sale | 100 | 108.43 | 10,843 |
2018-02-27 | CRL | Charles River Laboratories International, Inc. | Option Ex | 2,158 | 76.67 | 165,453 |
2018-02-27 | CRL | Charles River Laboratories International, Inc. | Sale | 2,158 | 108.11 | 233,303 |
2018-02-26 | CRL | Charles River Laboratories International, Inc. | Sale | 3,868 | 107.40 | 415,407 |
2018-02-26 | CRL | Charles River Laboratories International, Inc. | Option Ex | 4,187 | 73.70 | 308,581 |
2018-02-26 | CRL | Charles River Laboratories International, Inc. | Sale | 319 | 108.53 | 34,620 |
2018-02-16 | CRL | Charles River Laboratories International, Inc. | Sale | 3,639 | 108.75 | 395,730 |
2018-01-02 | CRL | Charles River Laboratories International, Inc. | Sale | 5,486 | 109.52 | 600,848 |
2018-01-02 | CRL | Charles River Laboratories International, Inc. | Option Ex | 16,817 | 51.45 | 865,234 |
2018-01-02 | CRL | Charles River Laboratories International, Inc. | Sale | 3,100 | 110.40 | 342,249 |
2018-01-02 | CRL | Charles River Laboratories International, Inc. | Sale | 8,231 | 110.02 | 905,566 |
2017-08-14 | CRL | Charles River Laboratories International, Inc. | Sale | 2,552 | 92.99 | 237,313 |
2017-08-14 | CRL | Charles River Laboratories International, Inc. | Option Ex | 1,249 | 76.12 | 95,073 |
2017-06-08 | CRL | Charles River Laboratories International, Inc. | Sale | 945 | 95.00 | 89,775 |
2017-06-08 | CRL | Charles River Laboratories International, Inc. | Option Ex | 945 | 51.45 | 48,620 |
2017-03-03 | CRL | Charles River Laboratories International, Inc. | Option Ex | 11,640 | 69.48 | 808,805 |
2017-03-03 | CRL | Charles River Laboratories International, Inc. | Sale | 7,750 | 87.91 | 681,271 |
2017-03-03 | CRL | Charles River Laboratories International, Inc. | Sale | 3,890 | 88.16 | 342,938 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smith David Ross (Corporate Executive VP & CFO of Charles River Laboratories International, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.